“Reverse your biological age” has become one of the most common claims in the longevity space — appearing in book titles, supplement marketing, and breathless science journalism. The claim is not obviously false. There is genuine evidence that certain interventions produce measurable reductions in biological age as assessed by current measurement tools. There is also substantial reason for caution about what those measurements actually mean, how reliably they track the biology they are supposed to represent, and whether a lower clock reading translates to the extended healthy lifespan that is the ultimate goal.
This article examines what biological age is, how it is measured, what the evidence shows about reversing it, and how to think about biological age claims with appropriate skepticism and appropriate openness.
Chronological Age vs. Biological Age
Chronological age is simply time elapsed since birth — precise, unambiguous, and entirely outside anyone’s control. Biological age is a fundamentally different concept: it attempts to capture the functional and molecular state of the body’s aging process, independent of how many years have passed. Two people who are both 60 years old chronologically may be in very different biological states — one metabolically healthy, physically fit, with well-preserved cellular function; the other with insulin resistance, reduced cardiovascular capacity, and more advanced cellular deterioration. The goal of biological age measurement is to quantify that difference in a way that predicts health outcomes better than chronological age alone.
The appeal of biological age as a concept is that it is potentially modifiable — unlike chronological age. If a 60-year-old has a measured biological age of 52, either that individual has aged more slowly than average or their current interventions are producing a rejuvenation effect. Either way, the measurement suggests something about their trajectory that chronological age cannot capture. The question is how well current measurement tools actually capture that trajectory.
The science of biological aging and the concept of healthspan are covered in the foundational articles on the science of biological age and healthspan vs. lifespan.
How Biological Age Is Currently Measured
Several measurement approaches exist, with different mechanistic bases and different predictive validities.
Epigenetic Clocks
Epigenetic clocks are currently the most sophisticated and widely used biological age measurement tools. They are based on DNA methylation — the addition of methyl groups to specific cytosine residues in the genome that occurs in characteristic age-related patterns. Certain CpG sites across the genome gain methylation with age while others lose it, and these patterns are so consistent across individuals that they can be used to predict chronological age from methylation data with remarkable accuracy.
Steve Horvath’s 2013 clock — developed using methylation data from hundreds of cell types and tissues — predicted chronological age from methylation at 353 CpG sites with a median error of less than 4 years. Subsequent clocks have been developed with different objectives: Hannum’s blood-based clock, the PhenoAge clock (Levine et al., 2018) trained on clinical biomarkers to predict phenotypic age, and GrimAge (Lu et al., 2019), currently the best predictor of mortality and disease risk among available clocks.
The key distinction among clocks is what they are trained to predict. Horvath’s original clock predicts chronological age; GrimAge predicts mortality; PhenoAge predicts disease burden. A lower reading on GrimAge — meaning the person’s methylation pattern resembles that of someone with lower mortality risk — is more directly relevant to longevity than a lower reading on a clock trained to predict calendar years.
Telomere Length
Telomeres — protective caps on chromosomes that shorten with each cell division — were one of the first proposed biological age measures. Average telomere length decreases with age and shorter telomeres are associated with increased disease risk and mortality in epidemiological studies. However, telomere length is highly variable between individuals, shows substantial measurement variability, and is affected by many factors beyond aging. As a biological age measure it is less precise and less predictive than modern epigenetic clocks.
Composite Biomarker Panels
Several biological age assessments use panels of standard clinical biomarkers — blood counts, metabolic markers, inflammatory markers, functional measures — to estimate biological age. The PhenoAge approach uses nine biomarkers including albumin, creatinine, glucose, CRP, lymphocyte percentage, and others. These composite measures have the advantage of being derivable from standard blood tests and have meaningful predictive validity for mortality and disease outcomes.
Functional and Physical Measures
Grip strength, gait speed, VO2 max, and cognitive test performance are functional measures that age in characteristic ways and predict mortality risk independently. They are not “biological age” measurements in the molecular sense but are well-validated predictors of aging outcomes that can be tracked over time and respond to interventions.
What “Reversing” Biological Age Means in Practice
When someone claims to have “reversed their biological age,” they typically mean one of two things: either a repeated epigenetic clock measurement showed a lower number after an intervention than before it, or a composite biomarker panel improved in the direction of younger values. Both are meaningful observations. Neither definitively establishes that the person is now biologically younger in the sense that matters most — that they will live longer or remain healthier for a longer period than they would have without the intervention.
The gap between “my clock reading went down” and “I will live longer and healthier” is not trivial. Epigenetic clocks measure methylation patterns at specific CpG sites. If an intervention changes methylation at those sites in ways that make the pattern resemble younger tissue, the clock reads younger. Whether that methylation change reflects genuine cellular rejuvenation — restored youthful gene expression, better functional capacity, reduced disease risk — or a specific methylation response to the intervention that does not represent broad biological rejuvenation is a question the field has not definitively answered.
GrimAge is the clock most directly validated against mortality outcomes, and a reduction in GrimAge in response to an intervention is a more meaningful signal than a reduction in Horvath’s original chronological predictor. But even GrimAge validation comes from population-level observational data — whether interventional changes in GrimAge reliably predict changes in individual mortality risk is an assumption that has not been directly tested in sufficiently large, long-term trials.
Evidence That Biological Age Can Be Reduced
With those caveats stated, there is genuine and growing evidence that certain interventions produce measurable reductions in biological age as assessed by current tools.
The Horvath Clock and Lifestyle Interventions
A well-designed trial by Fitzgerald et al. (2021) in Aging enrolled 43 healthy middle-aged men in an 8-week program combining dietary modifications (plant-rich, limited simple carbohydrates, specific functional foods), exercise, sleep optimization, relaxation practices, and targeted supplementation (probiotics, phytonutrients). DNA methylation was measured at baseline and after 8 weeks. The intervention group showed a mean reduction of approximately 3.2 years on the Horvath clock compared to controls — a result that received significant attention as one of the first randomized controlled demonstrations of epigenetic age reduction in response to a comprehensive lifestyle intervention.
The limitations of this trial are real — small sample size, short duration, multicomponent intervention making it impossible to attribute the effect to any specific component — but it established proof of concept that epigenetic age is modifiable by lifestyle intervention in a controlled experimental design.
Partial Cellular Reprogramming
The most dramatic biological rejuvenation evidence comes not from supplementation but from cellular reprogramming research. Yamanaka factors — the four transcription factors (Oct4, Sox2, Klf4, c-Myc) that can reprogram differentiated cells back to a pluripotent state — reset the epigenetic clock to near-zero when fully expressed. The practical problem is that full reprogramming also erases cell identity, making cells tumorigenic.
The breakthrough insight from Sinclair’s laboratory, published by Lu et al. (2020) in Nature, was that partial, transient expression of three of the four Yamanaka factors (Oct4, Sox2, Klf4 — omitting c-Myc to reduce cancer risk) could partially reset the epigenetic state of retinal ganglion cells in aged mice without causing loss of cell identity or tumor formation. Mice treated with this approach showed improvements in visual function after optic nerve damage that were not seen in controls. Subsequent work from Sinclair’s and other laboratories has extended partial reprogramming to other tissues and contexts.
Partial cellular reprogramming is not a supplement strategy — it requires gene therapy or viral vector delivery of transcription factors. But it is the most direct experimental evidence that the epigenetic state underlying biological age can be reset in a mammalian system, and it provides biological plausibility for the idea that biological age reversal is not fundamentally impossible — just not currently achievable through any accessible intervention.
NAD+ Precursors and Epigenetic Age
The Igarashi et al. (2022) NMN trial found a reduction in a biological age composite measure in the NMN group. Some participants in observational and intervention contexts monitoring their own epigenetic age have reported reductions coinciding with NAD+ precursor supplementation. These are preliminary signals rather than established findings — no large, well-powered randomized trial has demonstrated that NMN or NR supplementation produces statistically significant, reproducible reductions in validated epigenetic age clocks in healthy adults.
The mechanistic argument for NAD+ precursors influencing epigenetic age is coherent: SIRT1 activation supports proper histone deacetylation and chromatin maintenance, potentially slowing the epigenetic drift that drives clock aging. But the translation from mechanistic plausibility to measured clock reduction in humans remains to be established with the rigor that would support confident claims.
The Measurement Problem: What Clocks Can and Cannot Tell You
Understanding the limitations of epigenetic clocks is essential for interpreting biological age claims honestly — including claims about your own clock readings if you use consumer testing services.
First, epigenetic clocks have measurement variability. Repeated measurements on the same individual at the same biological state will not produce exactly the same number due to technical variation in methylation measurement and biological fluctuation in methylation patterns. A one-time reduction in clock reading of 2–3 years between measurements could reflect genuine biological change, measurement noise, or both. Meaningful trends require multiple repeated measurements over time.
Second, clocks are calibrated on population averages. A clock reading of 52 at chronological age 60 means the methylation pattern more closely resembles the average for a 52-year-old than a 60-year-old in the training population. It does not mean the individual has the health and longevity trajectory of the average 52-year-old. Individual health trajectories are more variable than population calibrations can capture.
Third, different clocks can give different readings on the same person. Horvath’s clock, GrimAge, and PhenoAge do not always agree, and improvements on one clock do not necessarily reflect improvements on others. The most informative approach uses multiple clocks and tracks trends over time rather than placing excessive weight on any single measurement.
Fourth, not all methylation changes that reduce clock readings represent genuine rejuvenation. Some interventions may alter methylation at clock CpG sites through mechanisms that do not reflect broader biological rejuvenation — producing a lower clock reading without the functional improvements that the clock is supposed to predict. This concern is theoretical but real, and it is why independent validation of clock changes against functional outcomes matters.
What This Means Practically
For the longevity supplement user, the biological age question resolves to a few practical conclusions. Biological age testing — using validated consumer services offering GrimAge or PhenoAge assessments — is a reasonable way to track the aggregate effect of a longevity protocol over time. Not as a definitive measure of success or failure, but as one signal among several that can be monitored alongside functional measures (VO2 max, grip strength, cognitive assessments) and standard clinical biomarkers (CRP, HbA1c, fasting insulin).
The evidence that biological age is modifiable by lifestyle and potentially by supplementation is real. The evidence that the available measurement tools reliably capture the trajectory that matters most — long-term healthspan and lifespan — is promising but not yet conclusive. Treating a biological age test result as ground truth about your aging trajectory overstates what current science supports; dismissing it as meaningless marketing dismisses a genuinely informative measurement whose predictive validity, while imperfect, is better than most people appreciate.
Frequently Asked Questions
Which biological age test should I use?
For the most mortality-relevant reading, a test offering GrimAge or PhenoAge is preferable to one offering only Horvath’s original clock, which predicts chronological age rather than mortality risk. Several direct-to-consumer services offer methylation-based epigenetic age testing at accessible price points. Consistency matters — using the same service for repeated measurements over time is more informative than comparing results across different platforms, which may use different normalization approaches. Most services recommend retesting every six to twelve months to identify trends rather than point estimates.
If I reverse my epigenetic age, does that mean I will live longer?
Not necessarily, in any individual case. The clocks’ predictive validity is established at the population level — people with lower GrimAge readings have lower average mortality risk in the populations studied. Whether an interventional reduction in your personal GrimAge reading will translate to a proportional change in your individual mortality risk is an assumption that has not been directly tested. The most accurate framing is that reducing biological age as measured by current clocks is associated with reduced aging-related disease risk in population data, and represents the best available proxy for genuine biological rejuvenation — while acknowledging that it is a proxy, not a direct measurement of longevity.
Can stress or illness temporarily increase biological age readings?
Yes. Acute illness, psychological stress, and significant metabolic disruption have been associated with transient increases in epigenetic age measures in some studies. This reflects that methylation patterns are responsive to physiological state rather than being fixed at any given time. It also reinforces the importance of consistency in measurement conditions — testing shortly after an illness, a period of major stress, or significant sleep disruption may produce a less representative reading than testing under baseline conditions.
Is biological age reversal achievable through supplements alone?
Almost certainly not, based on current evidence. The most impressive biological age reductions demonstrated experimentally — the Fitzgerald lifestyle trial, the Lu et al. partial reprogramming experiments — involved either comprehensive multicomponent lifestyle change or direct genetic intervention. The contribution of any individual supplement to epigenetic age reduction, even one with strong mechanistic rationale like NMN, has not been established as sufficient on its own to produce reliable, meaningful clock reductions in controlled human trials. Supplements are most plausibly one element of a broader protocol — alongside exercise, sleep optimization, dietary quality, and stress management — that together produce the aggregate biological state that clocks attempt to measure.